Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Localized Pancreatic Adenocarcinoma · Borderline Resectable Pancreatic Adenocarcinoma · Resectable Pancreatic Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations